Caricamento...
ViruClear: Molecularly designed biomimetic nanosponges for prevention and treatment of SARS‐CoV‐2 infections in COVID‐19 patients
The current COVID‐19 pandemic infectious disease agent SARS‐CoV‐2, like its’ cousin SARS‐CoV, uses a variety of entry receptors including angiotensin converting enzyme‑2 (ACE2), L‐SIGN (CD209L), and DC‐SIGN and others. The interaction between SARS‐CoV‐2 spike protein and host cell proteins is the fi...
Salvato in:
| Pubblicato in: | FASEB J |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
The Federation of American Societies for Experimental Biology
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8239890/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fasebj.2021.35.S1.04581 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|